Cardiogenic shock and high-risk interventions with percutaneous mechanical circulatory support: new evidence and insights
<p class="moderator speaker-name">Anchorperson: <span classs="personname">Alaide Chieffo</span></p><p class="moderator speaker-name">Discussants: <span classs="personname">Mirvat Alasnag, Vasileios Panoulas, Giuseppe Tarantini</span></p>
Watch this session if you want
<ul> <li>To learn the latest data on Impella in cardiogenic shock</li> <li>To learn on how to improve survival of cardiogenic shock patients</li> <li>To see latest data and EAPCI consensus on high-risk PCI in patients unsuitable for surgery</li> </ul>
<div class="intervention"><div class="interventionTitle">Welcome and session objectives</div><p class="speaker-intervention-name-img">Alaide Chieffo</p></div><div class="intervention"><div class="interventionTitle">High-risk percutaneous coronary intervention in patients with reduced left ventricular ejection fraction (pPCI)</div><p class="speaker-intervention-name-img">Mirvat Alasnag</p></div><div class="intervention"><div class="interventionTitle">Breaking down cardiogenic shock: an analytical reflection on the DanGer-SHOCK and ECLS-SHOCK trials</div><p class="speaker-intervention-name-img">Giuseppe Tarantini</p></div><div class="intervention"><div class="interventionTitle">One year post DanGer-Shock – Trial insights and subset analysis</div><p class="speaker-intervention-name-img">Vasileios Panoulas</p></div><div class="intervention"><div class="interventionTitle">Session evaluation and key learnings</div><p class="speaker-intervention-name-img">Alaide Chieffo</p></div>
